---
layout: full_article
title: "Retroperitoneal Pleomorphic Rhabdomyosarcoma in Adult: A Rare Case Report"
author: "Budi Martono, Sri Inggriani"
categories: jbn
canonical_url: https://jurnal.harianregional.com/jbn/full-60343 
citation_abstract_html_url: "https://jurnal.harianregional.com/jbn/id-60343"
citation_pdf_url: "https://jurnal.harianregional.com/jbn/full-60343"  
comments: true
---

<div><img src="https://jurnal.harianregional.com/media/60343-1.jpg" alt="" style="width:132pt;height:24pt;">
<p><span class="font2">P-ISSN:</span><a href="http://u.lipi.go.id/1481204884"><span class="font2"> 2548-5962</span></a></p>
<p><span class="font2">E-ISSN:</span><a href="http://u.lipi.go.id/1483969293"><span class="font2"> 2548-981X</span></a></p>
<p><a href="https://ojs.unud.ac.id/index.php/jbn"><span class="font2">https://ojs.unud.ac.id/index.php/jbn</span></a></p>
</div><br clear="all">
<div><a name="caption1"></a>
<h1><a name="bookmark0"></a><span class="font1" style="font-weight:bold;"><a name="bookmark1"></a>CASE REPORT</span></h1>
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/60343-2.jpg" alt="" style="width:103pt;height:65pt;">
</div><br clear="all">
<p><span class="font6" style="font-weight:bold;">Retroperitoneal Pleomorphic Rhabdomyosarcoma in Adult: A Rare Case Report</span></p>
<p><span class="font4" style="font-weight:bold;">Budi Martono<sup>1*</sup>, Sri Inggriani<sup>2</sup></span></p>
<ul style="list-style:none;"><li>
<p><span class="font3"><sup>1</sup> &nbsp;&nbsp;&nbsp;Staff of Emergency Department, Medistra Hospital, Jakarta.</span></p></li>
<li>
<p><span class="font3"><sup>2</sup> &nbsp;&nbsp;&nbsp;Head of Radiology Department, Medistra Hospital, Jakarta.</span></p></li></ul>
<p><span class="font3">*Penulis korespondensi: </span><a href="mailto:budimartono89@gmail.com"><span class="font3">budimartono89@gmail.com</span></a><span class="font3">.</span></p>
<p><span class="font4" style="font-weight:bold;">ABSTRACT</span></p>
<p><span class="font4" style="font-weight:bold;">Background: </span><span class="font4">Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children, however, RMS is a rare malignancy in adults. Head and neck are the most common site for RMS, while intrabdominal RMS are rare in adults</span><span class="font4" style="font-style:italic;">.</span><span class="font4" style="font-weight:bold;"> Case: </span><span class="font4">We present a rare case of a retroperitoneal abdominal mass, treated surgically with histopathology results of a retroperitoneal RMS. We discuss the clinical presentation, image findings, and treatment for this case. </span><span class="font4" style="font-weight:bold;">Conclusion: </span><span class="font4">Intraabdominal tumours need to be identified quickly and precisely. CT scan or MRI can help clinicians to determine the staging, therefore plans the best treatment for the patient. In our case, surgery and radiotherapy showed promising outcome. The lack of literature and consensus on a standardized approach to systemic treatment and outcome in retroperitoneal pleomorphic RMS in adults makes our case a rare presentation of rhabdomyosarcoma and thus the need for reporting.</span></p>
<p><span class="font4" style="font-weight:bold;">Keywords: </span><span class="font4">rhabdomyosarcoma, retroperitoneal, pleomorphic.</span></p>
<p><span class="font4" style="font-weight:bold;text-decoration:underline;">DOI: </span><a href="https://doi.org/10.24843/JBN.2020.v04.i02.p04"><span class="font4" style="font-weight:bold;text-decoration:underline;">https://doi.org/10.24843/JBN.2020.v04.i02.p04</span></a></p>
<h2><a name="bookmark2"></a><span class="font5" style="font-weight:bold;"><a name="bookmark3"></a>INTRODUCTION</span></h2>
<p><span class="font5">Soft tissues sarcomas make up &gt;1% of all adult malignancies and RMS is only represent 3% from these soft tissue sarcomas.<sup>1 </sup>Rhabdomyosarcoma is a highly malignant mesenchymal tumour, originating from immature striated muscle.<sup>2</sup> Usually RMS can be discovered as a tumour in the head and the neck (35%), the genitourinary tract (22%), and other extremities (18%). There are four different sub-types of RMS defined by WHO classification by their histologic features: embryonal, alveolar, pleomorphic and spindle cell/sclerosing.<sup>3</sup> The histologic distribution of RMS differs in adults than young children.<sup>4 </sup>The pleomorphic subtype is more often encountered in adult patients and also carries the worst prognosis.<sup>2,5</sup></span></p>
<h2><a name="bookmark4"></a><span class="font5" style="font-weight:bold;"><a name="bookmark5"></a>CASE REPORT</span></h2>
<p><span class="font5">A 46 years old Indonesian male, came with complaint of change in urinating frequency</span></p>
<p><span class="font5">followed by palpable mass growing on his left lower abdomen within 1 month prior of examination. On physical examination, we found a palpable mass on the left lower quadrant, no tenderness, with size of 10 cm, smooth surface, firm consistency, and immobile. His blood laboratories are within normal limit. Lower abdominal ultrasound showed solid mass on the left pelvic side near the bladder with size measuring Â± 9.93 cm x 11.15 cm x 11.55 cm and spot of vascularity intra-tumour on Colour Doppler Sonography while kidney, bladder and prostate within normal (</span><span class="font5" style="font-weight:bold;">Figure 1</span><span class="font5">).</span></p>
<p><span class="font5">Abdominal CT (computed tomography) scan with contrast showed solid, smooth bordered, hyper-vascular mass, which show fine septation intratumor, seen located in the left hemi pelvis, measures 12.6 cm x 12.1 cm x 10.9 cm, and has a feeding artery originating from the aorta abdominal-infrarenal level (</span><span class="font5" style="font-weight:bold;">Figure 2</span><span class="font5">).</span></p>
<div>
<p><span class="font4">62 </span><span class="font4" style="font-weight:bold;">| </span><span class="font0">JBN (Jurnal Bedah Nasional)</span></p>
</div><br clear="all">
<p><span class="font5">No calcification is seen intratumor. The tumour caused a superior displacement of the sigmoid, caudal-medial warts of the tumour reaches until the level of upper bladder; the posterolateral part of the tumour reaches until the left iliopsoas margin. No peritumoral fat infiltration is seen in the surrounding tumour. There is no liver mass/ metastasis seen. No pathological lymph nodes metastasis in the pelvis nor retroperitoneal. The mass is suspected as a sarcomatous tumour or GIST (gastrointestinal stromal tumor). Upon Imaging results, we conclude the patient to have a stage 3 tumour (staging of T2bN0M0 using the TNM classification).</span></p><img src="https://jurnal.harianregional.com/media/60343-3.jpg" alt="" style="width:209pt;height:415pt;">
<p><span class="font4" style="font-weight:bold;">Figure 1. </span><span class="font4">Abdominal Ultrasound.</span></p><img src="https://jurnal.harianregional.com/media/60343-4.jpg" alt="" style="width:220pt;height:433pt;">
<p><span class="font4" style="font-weight:bold;">Figure 2. </span><span class="font4">Abdominal CT scan with contrast showed show solid, smooth bordered, hyper-vascular mass, which show fine septation intratumor, seen located in the left hemi pelvis, and has a feeding artery originating from the aorta abdominal-infrarenal level (green arrow).</span></p>
<p><span class="font5">The patient then undergoes laparotomy surgery, the patient was put under general anaesthesia, when the peritoneum was seen, the tumour is located at the left extraperitoneal pushing the sigmoid. Then the tumour was freed from its surrounding. There is an injury to the sigmoid serosa upon freeing the tumour, however it did not perforate the sigmoid which then repaired with suture, bleeding was controlled then the surgery site was then</span></p>
<p><span class="font5">closed. Macroscopically the mass is 14 cm x 10 cm x 8 cm, located retroperitoneal, with smooth margin, and easily distinguished from adjacent structure.</span></p><img src="https://jurnal.harianregional.com/media/60343-5.jpg" alt="" style="width:222pt;height:231pt;">
<p><span class="font4" style="font-weight:bold;">Figure 3. </span><span class="font4">Macroscopically feature of the mass.</span></p><img src="https://jurnal.harianregional.com/media/60343-6.jpg" alt="" style="width:219pt;height:296pt;">
<p><span class="font4" style="font-weight:bold;">Figure 4. </span><span class="font4">PET scan after surgery.</span></p><img src="https://jurnal.harianregional.com/media/60343-7.jpg" alt="" style="width:222pt;height:215pt;">
<p><span class="font4" style="font-weight:bold;">Figure 5. </span><span class="font4">Abdominal CT scan follow up 5 months after surgery, showed no visible mass and no residual tumour at the left pelvic.</span></p>
<p><span class="font5">The histopathological exam showed a tumour mass with defined border, with bundled spindle cell, hyperchromatic nuclei with some of them shaped bizarrely, and multi nucleated with mitosis 4/50 high-power fields. There is no invasion of lympho-vascular and necrosis seen. Immunohistochemistry (IHC) shows, CD 117 negative, S100 negative, SMA and vimentin is positive on the spindle cell, negative on the pleomorphic cells. Desmin and MyoD1 is positive on both spindle cell and pleomorphic cells. The IHC supported the diagnosis of pleomorphic rhabdomyosarcoma.</span></p>
<p><span class="font5">PET (positron emission tomography) scan was performed 2 months after surgery, it showed hypermetabolic lymph nodes enlargement at left external iliac suspect of metastatic process (</span><span class="font5" style="font-weight:bold;">Figure 4</span><span class="font5">). At the left intra cavum pelvic, obscure area was seen with mild metabolic activity at the area post-surgery, might be caused due to inflammation postsurgery or residual mass.</span></p>
<p><span class="font5">The patient then was consulted with oncologist and which then scheduled for radiation therapy and finished the radiation course without any complications. 5 months</span></p>
<p><span class="font5">after radiation therapy, the patient underwent another CT abdomen with contrast, which showed no visible mass and no residual tumour at the left pelvic while other abdomen organs are normal (</span><span class="font5" style="font-weight:bold;">Figure 5</span><span class="font5">). The patient is now currently well and actively working while still scheduled for periodic observation.</span></p>
<h2><a name="bookmark6"></a><span class="font5" style="font-weight:bold;"><a name="bookmark7"></a>DISCUSSION</span></h2>
<p><span class="font5">Most of the retroperitoneal neoplasms are malignant.<sup>16</sup> Usually, when they present clinical manifestation, it presents as a large mass tumour and involved surrounding</span></p>
<p><span class="font5">organs.<sup>11</sup> RMS usually comes from immature mesenchymal cells that relates to skeletal muscle lineage, but these tumours can grow in tissues in places where striated muscle is not normally found.<sup>17</sup> Retroperitoneal pleomorphic rhabdomyosarcoma (PRMS) in adult is extremely rare and also malignant. We searched for relevant literature of similar cases, however we found only a few case reports written in English that describe primary retroperitoneal pleomorphic RMS (</span><span class="font5" style="font-weight:bold;">Table 1</span><span class="font5">).<sup>5</sup></span></p>
<p><span class="font3" style="font-weight:bold;">Table 1. </span><span class="font3">Reported Cases of Retroperitoneal Rhabdomyosarcoma.</span></p>
<table border="1">
<tr><td colspan="5" style="vertical-align:bottom;">
<p><span class="font3" style="font-weight:bold;">Age</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Histology</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Metastasis</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Treatment</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Prognosis</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">No</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Reference</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">(y)</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Sex</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Presentation</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">1</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Kumar et al.<sup>6</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">61</span></p></td><td style="vertical-align:top;">
<p><span class="font3">M</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Lump, burning pain</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Spindle cell</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Inoperable,</span></p>
<p><span class="font3">Chemotherapy</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">2</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Yadav et al.<sup>7</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">65</span></p></td><td style="vertical-align:top;">
<p><span class="font3">M</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Abdominal pain, vomiting, obstipation</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Embryonal</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Inoperable, conservative</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">3</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Qadri et al.<sup>8</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">50</span></p></td><td style="vertical-align:top;">
<p><span class="font3">M</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Mass, constipation</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Pleomorphic</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Inguinal lymph node</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Surgery, radiotherapy, chemotherapy</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Died</span></p>
<p><span class="font3">(&lt;3 mo)</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font3">4</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Furlong et al.<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font3">32</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">M</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Pleomorphic</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Died (1 y)</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font3">5</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Furlong et al.<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font3">58</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">M</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Pleomorphic</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Died (1 y)</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">6</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Furlong et al.<sup>2</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">81</span></p></td><td style="vertical-align:top;">
<p><span class="font3">F</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Pleomorphic</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Died (1.5 y)</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">7</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Furlong et al.<sup>2</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font3">64</span></p></td><td style="vertical-align:top;">
<p><span class="font3">M</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Pleomorphic</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:top;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Died</span></p>
<p><span class="font3">(2 mo)</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font3">8</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Yu et al.<sup>10</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font3">37</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">F</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Mass</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Spindle cell</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">Surgery</span></p></td><td style="vertical-align:middle;">
<p><span class="font3">NA</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3">9</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Martono et al.*</span></p></td><td style="vertical-align:top;">
<p><span class="font3">46</span></p></td><td style="vertical-align:top;">
<p><span class="font3">M</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Mass, increase urine frequency</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Pleomorphic</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3">Left external iliac lymph node</span></p></td><td style="vertical-align:top;">
<p><span class="font3">Surgery, radiotherapy</span></p></td><td style="vertical-align:top;">
<p><span class="font3">No evidence of disease</span></p></td></tr>
</table>
<p><span class="font3">*note that the 9th case is the current case report. M = male; F = female; y = years; mo = month; NA = not available.</span></p>
<p><span class="font5">In a study performed by Furlong </span><span class="font5" style="font-style:italic;">et al</span><span class="font5">., PRMS is mentioned as a rare variant of RMS that almost always occurs in adults, with mean</span></p>
<p><span class="font5">age of 49 years and has a very poor prognosis.<sup>2 </sup>In our case, we also found similarities with</span></p>
<p><span class="font5">these findings. The tumour is often large (&gt;10 cm), and mostly fleshy, well-circumscribed.</span></p>
<p><span class="font5">Patient usually present without complaints such as pain, unless it is related to the mass effect or pain can be caused by complications that are secondary to the organs around the tumour (e.g. intra-abdominal tumours may present with bowel obstruction or compression upon adjacent neural structures). Therefore, imaging studies should include CT scan or MRI (magnetic resonance imaging) targeting the primary tumour to determine the size and possible involvement of other vital organ around the primary tumour; as findings in imaging studies can help surgeons in planning surgical resection.<sup>10</sup> Usually, RMS in CT scan or MRI shows as a mass lesion with areas of calcification, necrosis, and heterogeneous enhancement, with high-flow blood vessels in the tumor.<sup>11</sup></span></p>
<p><span class="font5">Understanding role of CT scan is important, in our case, from CT findings we can locate that the mass is at retroperitoneal space, it was seen located in the left hemipelvis, that cause a superior displacement of the sigmoid, pressing the upper part of bladder, and left iliopsoas margin as itâs posterior margin, and has feeding artery origin from the infrarenal level of abdominal aorta. These findings can help surgeon to determine the staging and plan the easies access to the mass. </span><span class="font5" style="font-weight:bold;">Figure 6 </span><span class="font5">showed how to evaluate intraabdominal lesion whether itâs a retroperitoneal or intraperitoneal tumour.</span></p>
<p><span class="font5">Pleomorphic rhabdomyosarcoma can be distinguished from embryonal and alveolar RMS based on histomorphology. Normally, on microscopic examination the tumour cells are seen to be arranged in sheets and lobules. Cells are pleomorphic, with round to elongated nuclei and abundant eosinophilic cytoplasm. However, it could easily be confused with undifferentiated high-grade pleomorphic sarcoma (malignant fibrous</span></p>
<p><span class="font5">histiocytoma) that is why IHC analysis plays an important role to address specific skeletal muscle markers and nonspecific myoid markers for achieving the diagnosis of PRMS.<sup>8,9</sup> RMS in IHC analysis shows high sensitivity and specificity for MyoD1 and/or myogenic positive which shows distinction from other adult pleomorphic soft tissue sarcomas.<sup>12</sup> The histopathologic findings in our case is positive immunoreactivity to desmin and MyoD1 antibodies, therefore it is concluded to be a PRMS.</span></p><img src="https://jurnal.harianregional.com/media/60343-8.jpg" alt="" style="width:215pt;height:230pt;">
<p><span class="font4" style="font-weight:bold;">Figure 6. </span><span class="font4">Step to identify the lesion whether its intra or retroperitoneal (RP).<sup>18</sup></span></p>
<p><span class="font5">Due to the rarity of the case, there is little information on the management and prognosis of the patient. Current guidelines for treating RMS in adult patients are based on the Intergroup Rhabdomyosarcoma Studies (IRS) which is based on treating children with RMS.<sup>13</sup></span></p>
<p><span class="font5">There are three main choice of treating patients with RMS. These are surgery, radiation therapy (RT) and systemic combination chemotherapy.<sup>8</sup> Surgery is the therapy of choice for adult RMS, as it seen to improved survival rate<sup>14</sup>. In IRSG protocols,</span></p>
<p><span class="font5">all RMS patient should get RT in order to control the tumour locally in case of any residual tumour after surgery.<sup>15</sup>In our case, the patient undergo surgery with radiotherapy post-surgery which showed promising result. Patient follow-up plan is with a PET scan examination 6 month after surgery and 12 months after, once ensured there is no residual mass.</span></p>
<h2><a name="bookmark8"></a><span class="font5" style="font-weight:bold;"><a name="bookmark9"></a>CONCLUSION</span></h2>
<p><span class="font5">Intraabdominal tumour needs to be identified quickly and precisely. CT scan or MRI can help clinicians to determine the staging, therefore plans the best treatment for the patient. In our case, from histopathology results was confirmed to be PRMS which is a malignant tumour with poorer outcome in adults than in paediatric population. However, it seems that in our case, with surgery and radiotherapy the patient showed promising outcome. We conclude that treatment of retroperitoneal PRMS in adults should follow the treatment standard of PRMS in paediatric case until more cases have been evaluated or an adult adjusted guideline is available.</span></p>
<p><span class="font5">The lack of literature and consensus on a standardized approach to systemic treatment and outcome in retroperitoneal pleomorphic RMS in adults makes our case a rare presentation of rhabdomyosarcoma in adults and thus the need for reporting.</span></p>
<h2><a name="bookmark10"></a><span class="font5" style="font-weight:bold;"><a name="bookmark11"></a>CONFLICT OF INTEREST</span></h2>
<p><span class="font5">We declare no conflict of interest.</span></p>
<h2><a name="bookmark12"></a><span class="font5" style="font-weight:bold;"><a name="bookmark13"></a>REFERENCE</span></h2>
<ul style="list-style:none;"><li>
<p><span class="font5">1. &nbsp;&nbsp;&nbsp;Weiss SW, Goldblum JR, Folpe AL. </span><span class="font5" style="font-style:italic;">Enzinger and Weiss' soft tissue tumors, 5th edition</span><span class="font5">. Philadelphia: Mosby; 2007. p.601-38.</span></p></li>
<li>
<p><span class="font5">2. &nbsp;&nbsp;&nbsp;Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: A clinicopathologic study of 38</span></p></li></ul>
<p><span class="font5">cases with emphasis on morphologic variants and recent skeletal musclespecific markers. </span><span class="font5" style="font-style:italic;">Mod Pathol</span><span class="font5">. 2001;14:595-603.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">3. &nbsp;&nbsp;&nbsp;Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. </span><span class="font5" style="font-style:italic;">WHO Classification of Tumors of Soft Tissue and Bone, 4<sup>th </sup>Edition, Volume 5</span><span class="font5">. France: IARC Press; 2013. p.127-34.</span></p></li>
<li>
<p><span class="font5">4. &nbsp;&nbsp;&nbsp;Sultan I, Qaddoumi I, Yaser S, et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. </span><span class="font5" style="font-style:italic;">J Clin Oncol</span><span class="font5">. 2009;27:3391-7.</span></p></li>
<li>
<p><span class="font5">5. &nbsp;&nbsp;&nbsp;Alkhormi AM, Alqifari A, Aljarbou OZ, et al. Primary duodenal embryonal rhabdomyosarcoma in adults: a case report. </span><span class="font5" style="font-style:italic;">AME Case Rep.</span><span class="font5"> 2019;3:29.</span></p></li>
<li>
<p><span class="font5">6. &nbsp;&nbsp;&nbsp;Kumar H, Heroor A, Vanan A, et al. IntraAbdominal &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retroperitoneal</span></p></li></ul>
<p><span class="font5">Rhabdomyosarcoma in Adult: A Rare Case Report &amp;&nbsp;Review of Literature. </span><span class="font5" style="font-style:italic;">IOSR Journal of Dental and Medical Sciences</span><span class="font5">. 2017;16:36-8.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">7. &nbsp;&nbsp;&nbsp;Yadav SK, Sinha DK, Ahmed A, Azhar T, et al. Primary Intra-Abdominal Rhabdomyosarcoma in an Adult: an Unusual Presentation and Review of Literature. </span><span class="font5" style="font-style:italic;">Indian J Surg Oncol</span><span class="font5">. 2015;6:119-22.</span></p></li>
<li>
<p><span class="font5">8. &nbsp;&nbsp;&nbsp;Qadri S, Alam K, Alam F. Retroperitoneal pleomorphic &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;rhabdomyosarcoma</span></p></li></ul>
<p><span class="font5">metastasizing to inguinal lymph node. </span><span class="font5" style="font-style:italic;">Clin Cancer Investig J</span><span class="font5">. 2015;4:404-7.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">9. &nbsp;&nbsp;&nbsp;Yu L, Yang SJ. Spindle cell rhabdomyosarcoma &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the</span></p></li></ul>
<p><span class="font5">retroperitoneum: &nbsp;&nbsp;an unusual case</span></p>
<p><span class="font5">developed in a pregnant woman but obscured by pregnancy. </span><span class="font5" style="font-style:italic;">Int J Clin Exp Pathol</span><span class="font5">. 2014;7:4904-12.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">10. &nbsp;&nbsp;&nbsp;Egas-Bejar &nbsp;&nbsp;&nbsp;&nbsp;D, &nbsp;&nbsp;&nbsp;&nbsp;Huh &nbsp;&nbsp;&nbsp;&nbsp;WW.</span></p></li></ul>
<p><span class="font5">Rhabdomyosarcoma in adolescent and young adult patients: &nbsp;&nbsp;&nbsp;Current</span></p>
<p><span class="font5">perspectives.</span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069040/"><span class="font5"> </span><span class="font5" style="font-style:italic;">Adolesc Health Med Ther</span><span class="font5">.</span></a><span class="font5"> 2014;5:115-25.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">11. &nbsp;&nbsp;&nbsp;Rajiah P, Sinha R, Cuevas C, et al. Imaging of uncommon retroperitoneal masses. </span><span class="font5" style="font-style:italic;">Radiographics</span><span class="font5">. 2011;31:949-76.</span></p></li>
<li>
<p><span class="font5">12. &nbsp;&nbsp;&nbsp;Nakayama R, Nemoto T, Takahashi H, et al. Gene expression analysis of soft tissue sarcomas: &nbsp;&nbsp;&nbsp;&nbsp;Characterization &nbsp;&nbsp;&nbsp;&nbsp;and</span></p></li></ul>
<p><span class="font5">reclassification of malignant fibrous histiocytoma. </span><span class="font5" style="font-style:italic;">Mod Pathol</span><span class="font5">. 2007;20:749-59.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">13. &nbsp;&nbsp;&nbsp;Khosla D, Sapkota S, Kapoor R, et al. Adult Rhabdomyosarcoma: &nbsp;&nbsp;Clinical</span></p></li></ul>
<p><span class="font5">Presentation, Treatment, and Outcome. </span><span class="font5" style="font-style:italic;">J Cancer Res Ther</span><span class="font5">. 2015;11:830-4.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">14. &nbsp;&nbsp;&nbsp;Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients</span></p></li></ul>
<p><span class="font5">treated at a single institution. </span><span class="font5" style="font-style:italic;">Cancer</span><span class="font5">. 2003;98:571-80.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font5">15. &nbsp;&nbsp;&nbsp;Crist W, Gehan EA, Ragab AH. The third Intergroup Rhabdomyosarcoma Study. </span><span class="font5" style="font-style:italic;">J Clin Oncol</span><span class="font5">. 1995;13:610-30.</span></p></li>
<li>
<p><span class="font5">16. &nbsp;&nbsp;&nbsp;Neville A, Herts BR. CT characteristics of primary retroperitoneal neoplasms. </span><span class="font5" style="font-style:italic;">Crit Rev Comput Tomogr</span><span class="font5">. 2004;4:247-70.</span></p></li>
<li>
<p><span class="font5">17. &nbsp;&nbsp;&nbsp;Husband DJE, Reznek RH. </span><span class="font5" style="font-style:italic;">Husband and Reznek's Imaging in Oncology, 3rd Edition</span><span class="font5">. UK: Informa Healthcare; 2009. p.941-6.</span></p></li>
<li>
<p><span class="font5">18. &nbsp;&nbsp;&nbsp;Bhargavi DV, Avantsa R, Kala P. MDCT signs differentiating retroperitoneal and intraperitoneal lesions-diagnostic pearls. </span><span class="font5" style="font-style:italic;">Electronic Presentation Online System</span><span class="font5">. 2015:C-0987.</span></p></li></ul>
<p><span class="font4">68</span></p>